Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Figure out How to Forestall Tooth Staining - 2My prescription costs what?! Pharmacists offer tips that could reduce your out-of-pocket drug costs
- 3Step by step instructions to Choose the Right Auto Crash Legal counselor for Your Case
- 4Popular Film Areas: A Worldwide Manual for Film Enchantment
- 5Scientists find evidence that an asteroid contains tryptophan
- Poll: By a 2-to-1 margin, Americans say Trump has done more to raise prices than lower them
- Dominating Capable Mastercard Utilization: Key Contemplations
- Kids with smartphones by age 12 are at higher risk of health issues, study finds
- Creative Style: 10 Architects Reclassifying the Business
- $2,000 tariff rebate checks? 50-year mortgages? Making sense of Trump's new 'affordability' proposals.
- Exhaustive Experiences into Prudent Senior Living in the UK
- The most effective method to Shield Your Gold Ventures: Procedures and Precautionary measures
- Struggling to keep your New Year's resolutions? Here's how to keep yourself on track
- What to know about Jack Dorsey's new Vine revival, DiVine
